[Update ESC-Guideline: Myocardial Revascularization]

Patrick Behm1, Thomas Nührenberg2, Florian Bönner1

  • 1Klinik für Kardiologie, Pneumologie und Angiologie, Heinrich-Heine-Universität, Düsseldorf.

Insights

The 2018 European Society of Cardiology (ESC) guideline on myocardial revascularization introduces 20 new recommendations and modifies others. These updates cover diagnosis, strategy selection, and procedural aspects for heart revascularization.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • The European Society of Cardiology (ESC) periodically updates guidelines for myocardial revascularization.
  • The 2018 guideline reflects recent advancements and evidence in the field.
  • Understanding guideline changes is crucial for clinical practice.

Purpose of the Study:

  • To provide an overview of the novelties introduced in the 2018 ESC guideline on myocardial revascularization.
  • To highlight key changes in recommendations regarding diagnosis, strategy, and procedures.
  • To inform clinicians about updated best practices in cardiac revascularization.

Main Methods:

  • Review of the official 2018 ESC guideline document on myocardial revascularization.
  • Analysis and categorization of new, upgraded, and downgraded recommendations.
  • Summary of changes across preprocedural, intraprocedural, and postprocedural phases.

Main Results:

  • Introduction of twenty completely new recommendations (7 Class I, 5 Class IIa, 6 Class IIb, 2 Class III).
  • Four existing recommendations were upgraded, and six were downgraded.
  • Comprehensive changes span preprocedural (diagnosis, strategy), intraprocedural (revascularization), and postprocedural aspects.

Conclusions:

  • The 2018 ESC guideline incorporates significant updates to myocardial revascularization practices.
  • Clinicians should be aware of these changes to optimize patient care.
  • The guideline emphasizes a comprehensive approach to revascularization, from diagnosis to follow-up.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
149
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
194
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
232
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
592
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
349
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
238